Finland· FI-REL-REL64268
Hopledo
A levodopa und decarboxylasehemmer product containing levodopa + carbidopa monohydrate, registered in Finland by Zambon S.p.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Levodopa und decarboxylasehemmer is registered in 12 of 19 countries.
Countries holding a registration under ATC N04BA02 (levodopa und decarboxylasehemmer), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Levodopa und decarboxylasehemmer · ATC N04BA02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Levodopa + Carbidopa monohydrate
- Manufacturer
- Zambon S.p.A.
- Country
- Finland (FI)
- ATC code
- N04BA02
- ATC class
- Levodopa und Decarboxylasehemmer
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
158 interactions on record for levodopa und decarboxylasehemmer.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levodopa und decarboxylasehemmer · interactions on record
158 records
- 4 severe
- 122 moderate
- 14 minor
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- Methylthioninium chlorideV03AB17severe
18 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levodopa und decarboxylasehemmer in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCarbidopa/Levodopa Brillpharma 10mg/100mg, tablettenBrillpharma (Ireland) Limited
- United StatesCarbidopa and levodopaTeva Pharmaceuticals USA, Inc.
- CzechiaHOPLEDOZambon S.p.A., Bresso
- GermanyDuodopaAbbvie Deutschland Gmbh & Co. Kg
- FranceDUODOPA 20 mg/ml + 5 mg/ml, gel intestinalABBVIE
- SwedenCarbidopa/Levodopa Fair-Med 10 mg/100 mg TablettFairmed Healthcare GmbH
- IrelandCarbidopa/Levodopa Fair-Med 10 mg/100 mg TabletsFairmed Healthcare GmbH
- NorwayCarbidopa/Levodopa Fair-MedFair-Med Healthcare GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Duodopa
- Belgium · Duodopa, Precifit
- Bulgaria · Дуодопа, Синепар
- Cyprus · Duodopa
- Czechia · Duodopa, Isicom
- Germany · Duodopa, Isicom
- Denmark · Carbidopa/Levodopa Fair-Med, Levodopa/Carbidopa Teva
- Estonia · Duodopa
- Spain · Carbidopa/Levodopa Aurovitas, Carbidopa/Levodopa Kern Pharma
- France · Levodopa Carbidopa Teva
- United Kingdom (Northern Ireland) · Carbidopa/Levodopa Milpharm, Co-Careldopa
- Greece · Duodopa
- Croatia · Duodopa
- Hungary · Duodopa
- Ireland · Carbidopa/Levodopa Fair-Med, Duodopa
- Iceland · Duodopa
- Italy · Carbidopa E Levodopa Aurobindo, Duodopa
- Liechtenstein · Duodopa
- Lithuania · Duodopa, Levodopa/Carbidopa Fairmed
- Luxembourg · Duodopa, Precifit
- Latvia · Duodopa
- Netherlands · Carbidopa / Levodopa Brillpharma, Carbidopa/Levodopa Fair-Med
- Norway · Carbidopa/Levodopa Fair-Med, Duodopa
- Poland · Precifit
- Portugal · Duodopa, Levodopa + Carbidopa Generis
- Romania · Duodopa, Isicom
- Sweden · Carbidopa/Levodopa Fair-Med, Duodopa
- Slovenia · Duodopa
- Slovakia · Duodopa, Isicom
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d83e533a-7423-404e-8df2-fcb92cfe7b3f GET /v1/drugs/d83e533a-7423-404e-8df2-fcb92cfe7b3f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.6",
"form": "säädellysti vapauttava kapseli, kova",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "210 mg / 52.5 mg",
"atc_label": "levodopa ja dekarboksylaasin estäjä",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/26/2054/002",
"fimea_rel_id": "REL64268",
"authorised_at": "2026-08-20"
}See everything about levodopa und decarboxylasehemmer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.